Sinopharm Tech Holdings Limited (HK:8156)

:8156

8156

Sinopharm Tech Holdings Limited

RESEARCH TOOLSreports

Want to see HK:8156 full AI Analyst Report?

Sinopharm Tech Holdings Limited (8156) Price & Analysis

0 Followers

8156 Stock Chart & Stats

HK$0.22

HK$0.00(0.00%)

At close: Sep 30 4:00 PM EDT

HK$0.22

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.10 - HK$0.44

Previous CloseN/A

Volume194.40K

Average Volume (3M)157.92K

Market Cap

HK$183.77M

Enterprise ValueHK$198.11M

Total Cash (Recent Filing)HK$6.95M

Total Debt (Recent Filing)HK$46.73M

Price to Earnings (P/E)―

Beta0.25

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding633,693,050

10 Day Avg. Volume46,340

30 Day Avg. Volume157,918

Financial Highlights & Ratios

PEG Ratio1.01

Price to Book (P/B)-2.33

Price to Sales (P/S)1.40

P/FCF Ratio-11.93

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue GrowthA 224% year-over-year revenue surge indicates meaningful commercial traction and expanding customer adoption. Sustained top-line growth can enable operating leverage, support future margin recovery, and provide the base for reinvestment into product and sales capacity over the coming quarters.

Improving Free Cash FlowRecovery in free cash flow signals improving ability to convert revenue into internally generated funds. Over 2–6 months this can reduce reliance on external financing, allow deleveraging or targeted reinvestment, and improve financial flexibility if the trend persists.

Lean Operating BaseA small headcount implies a lean cost structure and potential for scalable revenue per employee. If revenue growth continues, this operating leverage can translate into faster margin expansion and efficient capital deployment, benefiting long-term profitability prospects.

Bears Say

Negative EquityNegative shareholders' equity is a structural solvency concern that limits the firm's financial flexibility. It increases vulnerability to shocks, constrains access to low-cost capital, and can impede long-term investment and strategic options until equity is repaired or liabilities reduced.

Negative Operating Cash FlowPersistently negative operating cash flow implies the core business is not yet self-sustaining and requires external funding to cover operations. This weakens long-term resilience, raises refinancing risk, and can force dilutive or costly financing if operational cash conversion doesn't improve.

Ongoing Profitability ShortfallSustained negative margins indicate the business is not generating returns on sales and limits retained earnings. Continued unprofitability undermines the firm's ability to self-fund growth and raises questions about unit economics and the path to durable, positive operating profit.

8156 FAQ

What was Sinopharm Tech Holdings Limited’s price range in the past 12 months?

Sinopharm Tech Holdings Limited lowest stock price was HK$0.10 and its highest was HK$0.44 in the past 12 months.

What is Sinopharm Tech Holdings Limited’s market cap?

Sinopharm Tech Holdings Limited’s market cap is HK$183.77M.

When is Sinopharm Tech Holdings Limited’s upcoming earnings report date?

Sinopharm Tech Holdings Limited’s upcoming earnings report date is Sep 25, 2026 which is in 149 days.

How were Sinopharm Tech Holdings Limited’s earnings last quarter?

Sinopharm Tech Holdings Limited released its earnings results on Feb 26, 2026. The company reported -HK$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.006.

Is Sinopharm Tech Holdings Limited overvalued?

According to Wall Street analysts Sinopharm Tech Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sinopharm Tech Holdings Limited pay dividends?

Sinopharm Tech Holdings Limited does not currently pay dividends.

What is Sinopharm Tech Holdings Limited’s EPS estimate?

Sinopharm Tech Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sinopharm Tech Holdings Limited have?

Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding.

What happened to Sinopharm Tech Holdings Limited’s price movement after its last earnings report?

Sinopharm Tech Holdings Limited reported an EPS of -HK$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.273%.

Which hedge fund is a major shareholder of Sinopharm Tech Holdings Limited?

Currently, no hedge funds are holding shares in HK:8156

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People's Republic of China and Hong Kong. The company operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, Manufacturing and Distribution of Personal Protective Equipment, and Other Services segments. It offers lottery-related hardware and software systems. The company is also involved in the provision of Internet plus solution services to health care, government affairs, leasing, public security, and other industries; and supply chain management, data analysis, and related services, as well as trading of goods through internet platform. In addition, it offers corporate management services; and distribution of personal protective equipment. The company was formerly known as China Vanguard You Champion Holdings Limited and changed its name to Sinopharm Tech Holdings Limited in June 2019. Sinopharm Tech Holdings Limited was founded in 1999 and is headquartered in Sha Tin, Hong Kong.